LAL assay

The Limulus Amebocyte Lysate assay, almost always called the LAL assay, is the standard in vitro test used to detect and quantify bacterial endotoxin (lipopolysaccharide) in a test article. The assay takes its name from the horseshoe crab Limulus polyphemus, whose blood cells (amebocytes) contain a clotting cascade that is exquisitely sensitive to endotoxin. Introducing even trace endotoxin into a lysate of those amebocytes initiates an enzymatic cascade that can be read out as a gel clot, a turbidity change, or the cleavage of a chromogenic substrate that produces a color. The LAL assay is the compendial method for bacterial endotoxins testing and is codified in USP General Chapter <85> Bacterial Endotoxins Test (USP <85>) and in the FDA Guidance for Industry: Pyrogen and Endotoxins Testing, 2012 (FDA 2012).

The three LAL formats

Three LAL formats are in common use. The gel-clot assay is the original format: the lysate either clots or does not at a given endotoxin concentration, and the lowest concentration at which a clot forms defines the endpoint. It is simple, does not require an instrument, and is often used as the referee method. The turbidimetric assay monitors the optical density of the reaction over time and gives a kinetic readout that is more amenable to automation. The chromogenic assay uses a synthetic substrate that releases a chromophore when cleaved by the activated clotting enzyme, producing a color whose intensity is proportional to the endotoxin concentration. Both kinetic formats provide a broader dynamic range and finer quantitation than gel clot.

Why endotoxin matters for peptide materials

Bacterial endotoxin is a heat-stable, lipid-rich component of the outer membrane of Gram-negative bacteria. It can enter a synthetic peptide preparation through contaminated water, glassware, reagents, or packaging, and it is not removed by ordinary sterile filtration in the way live organisms are. Endotoxin is relevant to any downstream use that would be confounded by an unintended immune stimulus, including cell-based assays, primary-cell culture, and any in vivo research model. For RUO materials, reporting the endotoxin level in EU/mg (endotoxin units per milligram of peptide) is the standard way to communicate how clean a preparation is with respect to this contaminant. An accessible methodology reference is Levin & Bang, Bull. Johns Hopkins Hosp. 1964 (NLM 14110468), and a modern review of recombinant alternatives (rFC) that sidestep horseshoe-crab sourcing is Bolden et al., PDA J. Pharm. Sci. Technol. 2020 (NLM 32817315).

What to look for on a COA

A rigorous COA reports the endotoxin method (gel clot, turbidimetric, chromogenic, or rFC), the result in EU/mg or EU/vial, and ideally the inhibition/enhancement screen that confirms the sample matrix does not interfere with the assay. "Endotoxin: pass" without a number or method is not informative. Open Assay captures the reported number and method when disclosed and marks listings without an endotoxin result as missing that field rather than claiming the material is low-endotoxin.